Cite

    Xu, S. et al. (2016). Evaluation of propensity scores, disease risk scores, and regression in confounder adjustment for the safety of emerging treatment with group sequential monitoring. Pharmacoepidemiology and drug safety. 25 (4), pp. 453-461. [Online].